Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Newly Discovered Polymorphism May Have Immediate Impact in HCV

This article was originally published in Start Up

Executive Summary

It's extraordinarily rare for a biomarker discovery to have a fast, clear-cut, and significant impact on a therapeutic area. But recent findings from a hepatitis C study--that a specific genetic variation strongly correlates with response to standard interferon-based therapy--could influence decision-making on when and how to treat certain HCV patients. What's more, the research may influence the design of clinical trials of new HCV agents and even trials in other diseases treated with interferon.
Advertisement

Related Content

A New Genetic Connection In Liver Cancer -- As Powerful As Her2/neu In Breast?
Novartis Follows Its Own Business Development Model into Molecular Diagnostics
Novartis Follows Its Own Business Development Model into Molecular Diagnostics
In HCV, Protease Race Heats Up with Combo Therapy Looming
In HCV, Protease Race Heats Up with Combo Therapy Looming
For GlobeImmune, Early HCV Vaccine Data May Spark Coveted Partnership

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC091848

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel